Ironwood Pharmaceuticals Inc (IRWD)
8.12
-0.18
(-2.17%)
USD |
NASDAQ |
May 03, 16:00
8.115
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Enterprise Value: 1.877B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.877B |
| May 02, 2024 | 1.905B |
| May 01, 2024 | 1.892B |
| April 30, 2024 | 1.819B |
| April 29, 2024 | 1.839B |
| April 26, 2024 | 1.830B |
| April 25, 2024 | 1.870B |
| April 24, 2024 | 1.874B |
| April 23, 2024 | 1.906B |
| April 22, 2024 | 1.867B |
| April 19, 2024 | 1.845B |
| April 18, 2024 | 1.795B |
| April 17, 2024 | 1.803B |
| April 16, 2024 | 1.841B |
| April 15, 2024 | 1.825B |
| April 12, 2024 | 1.839B |
| April 11, 2024 | 1.860B |
| April 10, 2024 | 1.856B |
| April 09, 2024 | 1.869B |
| April 08, 2024 | 1.861B |
| April 05, 2024 | 1.867B |
| April 04, 2024 | 1.881B |
| April 03, 2024 | 1.875B |
| April 02, 2024 | 1.892B |
| April 01, 2024 | 1.953B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.969B |
| March 27, 2024 | 1.955B |
| March 26, 2024 | 1.908B |
| March 25, 2024 | 1.922B |
| March 22, 2024 | 1.964B |
| March 21, 2024 | 2.019B |
| March 20, 2024 | 2.032B |
| March 19, 2024 | 1.991B |
| March 18, 2024 | 1.938B |
| March 15, 2024 | 2.018B |
| March 14, 2024 | 2.010B |
| March 13, 2024 | 1.958B |
| March 12, 2024 | 1.966B |
| March 11, 2024 | 2.007B |
| March 08, 2024 | 2.016B |
| March 07, 2024 | 2.004B |
| March 06, 2024 | 1.955B |
| March 05, 2024 | 2.065B |
| March 04, 2024 | 2.066B |
| March 01, 2024 | 2.025B |
| February 29, 2024 | 2.082B |
| February 28, 2024 | 2.972B |
| February 27, 2024 | 2.982B |
| February 26, 2024 | 2.958B |
| February 23, 2024 | 2.965B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.225B
Minimum
May 16 2023
3.024B
Maximum
Feb 14 2024
1.852B
Average
1.811B
Median
Apr 28 2020
Enterprise Value Benchmarks
| Societal CDMO Inc (DELISTED) | 145.26M |
| Mirum Pharmaceuticals Inc | 1.235B |
| Tharimmune Inc | -6.502M |
| Kineta Inc | 1.623M |
| Moderna Inc | 39.38B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.087M |
| Revenue (Quarterly) | 117.55M |
| Total Expenses (Quarterly) | 74.34M |
| EPS Diluted (Quarterly) | -0.01 |
| Profit Margin (Quarterly) | -0.92% |
| Earnings Yield | -80.17% |
| Operating Earnings Yield | 12.11% |
| Normalized Earnings Yield | -10.48 |